Testimonials

What colleagues & clients say

Recommendations from medical device leaders, project managers, clients and regulatory affairs peers I've worked alongside.

It was a pleasure working with Irene in her role as a Clinical Evaluation SME. She played a critical role at the intersection of clinical strategy, product design and regulatory requirements. She demonstrated a structured and strategic approach to complex challenges, is knowledgeable in analysing clinical evidence, identifying gaps and translating them into clear decision points critical during the development stage. She has the ability to step into moments of uncertainty and bring clarity by asking the right questions — displaying sound judgement in line with regulatory expectations. She is good at cross-functional collaboration to bridge clinical and engineering needs, transparent, and proactively solution-oriented. I highly recommend her for any role in the RA space, specifically around clinical evaluations.

Ravindra Peerannawar Medical Devices · Program & Project Management · Systems Engineering · V&V

I am pleased to recommend Dr. Irene for her outstanding contribution and professionalism during our collaboration on the design project. Dr. Irene has consistently demonstrated strong expertise in clinical evaluations and a solid understanding of subject-matter requirements. Her analytical approach, attention to detail and ability to translate complex requirements into practical solutions were particularly impressive. What sets Dr. Irene apart is her proactive attitude, willingness to take ownership and commitment to delivering high-quality work within timelines. She communicates effectively, collaborates well with cross-functional teams, and maintains a positive, solution-oriented mindset even in challenging situations. I strongly recommend Dr. Irene for future opportunities and am confident she will excel in her endeavors.

Ramjee Veturu General Manager · Delivering Complex Medical Device Programs On Time & Within Compliance

I had the pleasure of working with and overseeing Irene's contributions during our time together at Tata Elxsi in the Regulatory Affairs (Clinical) team. Irene consistently demonstrated a deep understanding of regulatory requirements, particularly for Class IIb and Class III medical devices. She served as the go-to expert for SSCP (Summary of Safety and Clinical Performance), playing a pivotal role in addressing Notified Body queries with precision and efficiency. She also acted as a Subject Matter Expert for AI validation initiatives in clinical writing, showcasing her adaptability and forward-thinking approach. I highly recommend Irene for any role that demands regulatory depth, strategic acumen and cross-functional leadership.

Ekta Agarwal, Ph.D. Regulatory Affairs (Clinical) Lead · Tata Elxsi

Irene served as a Technical Reviewer for clinical documents including CERs, CEPs and SSCPs, primarily for Class IIb and Class III medical devices. She worked actively to ensure good-quality work under stringent timelines and provided clear, structured feedback to improve the clinical depth of documents. She worked proactively and helped teammates achieve compliant regulatory documents. She is a great team player, and her expertise, attention to detail and analysis made her a key contributor in my team.

Sripathi Vattikuti Project Manager EU MDR · Clinical Evaluation Specialist · Medical Writing

I had the opportunity to work closely with Irene on multiple regulatory submissions for Class III implantable medical devices, particularly focusing on Notified Body responses and SSCP documents under EU MDR. Irene demonstrated a deep understanding of complex clinical and regulatory requirements, and her ability to present high-risk device data in a clear, compliant and structured manner was outstanding. She consistently approached challenges with precision, clinical insight and a solution-driven mindset. Irene is not only technically strong but also a great team player who brings professionalism and clarity to every collaboration.

Akanksha Jha Specialist · Clinical Evaluations · Tata Elxsi Limited

Clarity given on CDSCO, FDA/CE considerations, sequencing of regulatory documentation and the correct first steps was extremely valuable guidance — and much-needed, actionable direction for the journey ahead.

Startup Founder (Client) MedTech Company

Career development coaching

Career guidance in regulatory affairs

Verified LinkedIn reviews from professionals I've coached on breaking into and growing within regulatory affairs.

5.0

Dr. Irene's career guidance in Regulatory Affairs / Quality Assurance (RA/QA) is insightful, structured and truly personalized. She breaks down complex career decisions into clear, actionable steps and aligns them with real industry expectations. Her mentorship not only provides clarity but also boosts confidence in making the right career moves. Highly valuable for anyone serious about career growth — her passion to bring out the best information for the candidate was commendable.

Sowmya R Global Regulatory Affairs · Pharmacovigilance & Regulatory Writing
Career Development Coaching · Apr 2026
5.0

Thank you for the informative session. The discussion provided valuable clarity on regulatory requirements and their practical application in clinical evaluation. I particularly appreciated the insights on EU MDR 2017/745 and how to structure documentation effectively. This will definitely help me improve my approach in ongoing work.

Shalini Jatti Regulatory Affairs · EU MDR, CER & PMS
Career Development Coaching · Mar 2026
4.8

I would like to sincerely thank my career coach for their constant guidance and support. Your insights have helped me understand my strengths, improve my skills and gain clarity about my career path. You have always motivated me to step out of my comfort zone and aim higher.

Aditya Kadam Drug Safety Associate · Pharmacologist (M-Pharm)
Career Development Coaching · Mar 2026
5.0

Dr. Irene provided engaging and highly informative sessions, with a great overview of regulatory writing. I learned many new and valuable insights into medical device regulatory affairs. Thank you so much for this wonderful and enriching session!

Dr. Nikitha Reddy Ravula Public Health Professional
Career Development Coaching · Mar 2026
5.0

Dr. Irene's insights into the MedTech domain have been extremely valuable. Her guidance has helped me gain clarity on industry dynamics and career pathways in healthcare innovation. Thank you for the mentorship!

Dr. Swathy N Medical Devices · Clinical Research & Digital Health
Career Development Coaching · Feb 2026
5.0

She had good knowledge, excellent communication and real experience in regulatory affairs.

Dr. Janavi G Project Support Coordinator · Pharm D
Career Development Coaching · Mar 2026
5.0

It was great — I gained good knowledge about the field.

Amal Nair MRI Technologist
Career Development Coaching · Mar 2026
5.0

It was a great and knowledgeable experience.

Narmadha Sivakumar Regulatory Associate · CER, ISO 13485 & Risk Management
Career Development Coaching · Apr 2026

Case studies

How it works in practice

Anonymised engagements across EU MDR clinical evaluation and early regulatory strategy.

Case study 01 · EU MDR

Clinical Evaluation Strategy & CER Development for EU MDR Compliance

A medical device manufacturer required support developing a Clinical Evaluation Report (CER) for a Class IIb device. The challenge extended beyond document preparation — the client needed a structured clinical evidence strategy capable of supporting regulatory compliance, minimising rework and ensuring consistency across the product lifecycle. A four-stage framework was implemented: Discovery, Strategy, Execution and Defense.

The challenges

  • Limited clarity on the strength and sufficiency of existing clinical evidence (routes of clinical evidence required)
  • Potential gaps between intended purpose, risk management and clinical claims
  • The need for an audit-ready Clinical Evaluation Report
  • A requirement for alignment between CER, Risk and Technical Documentation
  • Future preparedness for Notified Body review and post-market evidence updates
1

Discovery & Regulatory Deep Dive

A detailed assessment of the device and its targeted regulatory market.

  • Review of the device in detail — technology, intended purpose, target population
  • Assessment of regulatory classification and pathway
  • Evaluation of existing technical and available clinical documentation
2

Clinical Evidence Strategy

Identifying evidence requirements and building a defensible clinical argument through the data sets.

  • Indications and claims mapping with State-of-the-Art assessment
  • Critical literature appraisal and benchmark evaluation
  • Safety and performance parameters from all clinical datasets
  • Benefit-risk assessment planning and identification of evidence gaps
3

Reproducible Regulatory Execution

Translating the strategy into regulatory deliverables aligned with EU MDR expectations.

  • Clinical Evaluation Report (CER)
  • Clinical evidence appraisal and data-set synthesis
  • Benefit-risk evaluation
  • Cross-functional alignment
4

Defending the Clinical Evidence

Maintaining defensibility throughout regulatory review from the Notified Body.

  • Preparation for potential Notified Body questions and responses
  • Evidence traceability review
  • Alignment of clinical conclusions with risk management outputs
  • Support for post-market evidence generation (where required)

Key takeaway

A successful Clinical Evaluation Report is the core evidence narrative proving safety, performance, risk management, post-market surveillance and regulatory strategy. By focusing on clarity, accuracy and proactive execution from the outset, the project delivered a predictable pathway toward compliance — with fewer surprises, fewer revisions and on-time delivery.

Case study 02 · Novel Class IIa

Building the Regulatory Foundation for a Novel Class IIa Medical Device

A manufacturer developing a novel Class IIa medical device required early-stage regulatory support to establish a clear and defensible pathway toward market approval. As the device incorporated innovative characteristics with no straightforward regulatory precedent, the project demanded careful consideration of intended purpose, device positioning, risk management and clinical strategy.

The challenges

  • How to describe the device to accurately reflect its technology and intended application
  • How to articulate the intended purpose without creating unnecessary regulatory burden
  • Which potential risks to consider at an early stage
  • How to structure the future clinical evaluation strategy
  • How to maintain consistency across regulatory, clinical and risk management documentation
1

Regulatory Foundation Development

Creating two critical regulatory deliverables to anchor every later decision.

Intended Use Development

  • Structured intended-purpose statements and target population
  • Clinical indications, limitations and outline claims
  • Literature search on the novelty; alignment with the anticipated pathway

Device Description Development

  • Comprehensive device characterisation and key technological features
  • Functional and operational descriptions
  • Regulatory positioning of the device concept
2

Clinical & Risk Strategy Development

Expanding scope into the strategic deliverables that shape development.

Preliminary Risk Management Plan

  • Early identification of hazards and hazardous situations
  • Risk management methodology aligned with ISO 14971 principles
  • Framework for future risk analysis activities

Clinical Evaluation Plan (CEP)

  • Preliminary clinical evidence strategy and evaluation objectives
  • Identification of evidence requirements
  • Roadmap for future clinical assessment activities

Outcomes & value delivered

The project established a cohesive regulatory foundation — alignment between regulatory, clinical and risk functions, early identification of regulatory challenges, improved consistency across technical documentation, reduced downstream rework and a structured pathway for clinical evidence generation. By investing in robust early-stage documentation, the client created a strategic framework that informed development decisions and supported efficient progression toward approval — proving that intended use, device description, clinical strategy and risk management are not isolated documents, but interconnected components that shape the success of a novel device program.

Let's discuss your project & requirement

And let's add your success story to this list.